Evidence map›Paper›PMID 35976280›Full record

ArticleMemorias do Instituto Oswaldo Cruz2022

Lack of association of the KIR and HLA class I ligands with ZIKV infection in south and southeast of Brazil.

Laise Nayana Sala Elpidio, Amarilis Giaretta de Moraes, Ieda Bernadete Volkweis Langer, Greicy Cezar do Amaral, Maria Luiza Moretti, Márcia Teixeira Garcia, Rodrigo Angerami, José Luiz Proenca-Modena, Karina Bispo-Dos-Santos, Matheus Cavalheiro Martini and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. The Role of Killer Ig-like Receptors in Diseases from A to Z.International journal of molecular sciences · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Laise Nayana Sala ElpidioUniversidade Estadual de Maringá, Programa de Pós-Graduação em Biociências e Fisiopatologia, Departamento de Análises Clínicas e Biomedicina, Maringá, PR, Brasil.
Amarilis Giaretta de MoraesUniversidade Estadual de Maringá, Programa de Pós-Graduação em Biociências e Fisiopatologia, Departamento de Análises Clínicas e Biomedicina, Maringá, PR, Brasil.
Ieda Bernadete Volkweis LangerFarmacêutica responsável pelo Laboratório da Unidade Central de Nova Prata do Iguaçu, Nova Prata do Iguaçu, PR, Brasil.
Greicy Cezar do Amaral15ª Regional de Saúde do Paraná, Maringá, PR, Brasil.
Maria Luiza MorettiUniversidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Medicina Interna, Campinas, SP, Brasil.
Márcia Teixeira GarciaUniversidade Estadual de Campinas, Divisão de Epidemiologia Hospitalar, Hospital das Clínicas, Campinas, SP, Brasil.
Rodrigo AngeramiDepartamento de Vigilância em Saúde Pública de Campinas, Campinas, SP, Brasil.
José Luiz Proenca-ModenaUniversidade Estadual de Campinas, Instituto de Biologia, Departamento de Genética, Microbiologia e Imunologia, Laboratório de Vírus Emergentes, Campinas, SP, Brasil.
Karina Bispo-Dos-SantosUniversidade Estadual de Campinas, Instituto de Biologia, Departamento de Genética, Microbiologia e Imunologia, Laboratório de Vírus Emergentes, Campinas, SP, Brasil.
Matheus Cavalheiro MartiniUniversidade Estadual de Campinas, Instituto de Biologia, Departamento de Genética, Microbiologia e Imunologia, Laboratório de Vírus Emergentes, Campinas, SP, Brasil.
Pierina Lorencini PariseUniversidade Estadual de Campinas, Instituto de Biologia, Departamento de Genética, Microbiologia e Imunologia, Laboratório de Vírus Emergentes, Campinas, SP, Brasil.
Christiane Maria AyoFaculdade de Medicina de São José do Rio Preto, Departamento de Biologia Molecular, Laboratório de Imunogenética, São José do Rio Preto, SP, Brasil.
Luiz Carlos de MattosFaculdade de Medicina de São José do Rio Preto, Departamento de Biologia Molecular, Laboratório de Imunogenética, São José do Rio Preto, SP, Brasil.
Cinara Cássia BrandãoFaculdade de Medicina de São José do Rio Preto, Departamento de Biologia Molecular, Laboratório de Imunogenética, São José do Rio Preto, SP, Brasil.
Maurício Lacerda NogueiraFaculdade de Medicina de São José do Rio Preto, Departamento de Doenças Infecciosas e Parasitárias, Laboratório de Pesquisa em Virologia, São José do Rio Preto, SP, Brasil.
Denise Cristina Mós Vaz OlianiFaculdade de Medicina de São José do Rio Preto, Departamento de Ginecologia e Obstetrícia, São José do Rio Preto, SP, Brasil.
Lígia Cosentino Junqueira Franco SpegiorinFaculdade de Medicina de São José do Rio Preto, Departamento de Ginecologia e Obstetrícia, São José do Rio Preto, SP, Brasil.
Quirino Alves de Lima NetoUniversidade Estadual de Maringá, Programa de Pós-Graduação em Biociências e Fisiopatologia, Departamento de Análises Clínicas e Biomedicina, Maringá, PR, Brasil.
Jeane Eliete Laguila VisentainerUniversidade Estadual de Maringá, Programa de Pós-Graduação em Biociências e Fisiopatologia, Departamento de Análises Clínicas e Biomedicina, Maringá, PR, Brasil.ORCID http://orcid.org/0000-0002-5815-7903
Faculdade de Medicina de São José do Rio Preto · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Estadual de Maringá · BRAdministração Regional de Saúde de Lisboa e Vale do Tejo · PTInstituto de Saúde · BRUniversidade Iguaçu · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZika virus (ZIKV) is an emerging arbovirus associated with foetal malformations and neurological complications. The infection is usually associated with mild symptoms. The comparison between the allelic frequency of polymorphic genes in symptomatic infected individuals in the population can clarify the pathogenic mechanisms of ZIKV. During ZIKV infection, cytokines are produced and natural killer (NK) cells are recruited, whose activation depends on signaling pathways activated by specific receptors, such as killer cell immunoglobulin-like receptors (KIR). These molecules interact with human leukocyte antigen (HLA) class I ligands and are encoded by polymorphic genes.

objectivesThis study aimed to evaluate the frequency of allelic variants of the genes encoding the KIR receptors and their HLA class I ligands in 139 symptomatic ZIKV-patients and 170 controls negative for the virus, and to evaluate the role of these variants for ZIKV susceptibility.

methodsKIR and HLA class I genes were genotyped using the polymerase chain reaction-sequence specific oligonucleotide (PCR-SSO) technique.

findingsNo significant differences in the frequency distribution of KIRs and KIR-HLA in patients compared to controls were observed. MAIN

conclusionsKIR and its HLA ligands might play a minor role in ZIKV infection in the south and southeast Brazilian individuals.

Indexed as

Zika VirusZika Virus InfectionBrazilGene FrequencyGenotypeHistocompatibility Antigens Class IHumansLigandsReceptors, KIRHistocompatibility Antigens Class ILigandsReceptors, KIR

Identifiers

PMID35976280
PMCPMC9377541
OpenAlexW4291784591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.